New Prospective Expanded German Registry of Incidental Gallbladder Carcinoma (PERSUASION)- a Perm… (NCT04896931) | Clinical Trial Compass
CompletedNot Applicable
New Prospective Expanded German Registry of Incidental Gallbladder Carcinoma (PERSUASION)- a Permanent Platform Including All Kind of Biliary Tract Cancers (BTC)
Germany159 participantsStarted 2022-07-12
Plain-language summary
Permanent, prospective, multicenter registry including all kind of oncological therapy lines and procedures, clinical outcome, translational research (biobanking) and QoL for all types of biliary tract cancers.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Known biliary-tract cancer including intrahepatic-, extrahepatic- and gallbladder carcinomas
* age ≥18 years
* signed informed consent form
* planned for (or recently started - i.e. within the last 21 days)) neoadjuvant, adjuvant or 1st line therapy
Exclusion Criteria:
* Patients who are unable to consent because they do not understand the nature, significance and implications of the registry and therefore cannot form a rational intention
* Patient under 18 years of age
* Patient's inability to complete QoL questionnaire or answer the questions.
* Second-line or further palliative therapies if the patient's first-line therapy was not documented within the study.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Establishment of BTC population
Timeframe: Through study completion, an average of 2 years
Trial details
NCT IDNCT04896931
SponsorInstitut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest